Virtual event, Worldwide : 16 - 17 February 2021
Speakers: Barbara Cahill - Senior Global Portfolio Manager, IHC, Cytology, SA Consumables & Karla Ruegemer - Market Development Manager Tissue Processing
"Working with the Revos tissue processor and the Lunaphore LabSat Research platform"
This sponsored scientific sessions will be streamed live to registered conference participants and afterwards will be available here for anyone to watch on demand until 15 August 2021.
Today’s challenges need modern solutions. As a global precision cancer diagnostics company, we strive to support researchers in their pursuit of diagnostic and treatment breakthroughs by providing groundbreaking technologies that meet the demands of an evolving medical research landscape. Two of Epredia’s newest solutions, the Revos™ Tissue Processor and the LabSat™ Research reagent delivery platform utilize new and innovative technologies to deliver increased workflow efficiency while enabling advanced quality results.
In this presentation, you will learn how the Revos™ Tissue Processor from Epredia helps your samples achieve the quality needed for the demands of molecular testing such as Next Generation Sequencing. Discover how Revos™ achieves rapid processing at ambient temperatures thanks to its unique canted-chamber design that allows for rotational agitation within the chamber.
In a study to determine the efficacy of the canted chamber, researchers found that fluid dynamics created by continually breaking the reagent’s surface tension during rotational agitation allowed the tissue to process 7X faster than the traditional processors in the study without the need for added heat. In another study, we compared high heat processing with ambient temperature processing, as well as length of processing time. The results showed on average, the reduced time and heat process of Revos™ delivered better RNA and DNA yields.
You will also experience the game-changing LabSat™ Research Platform, which provides ultra-rapid results thanks to its use of innovative microfluidic technology. Microfluidics enables efficient biomarker discovery and allows researchers to:
In a recent study estimating HER2 gene amplification in breast cancer, the microfluidic technology of the LabSat™ Research platform showed excellent linearity between antigen presence and signal intensity as compared to manual staining, highlighting the microfluidic chip’s ability to provide precise results.
If you see a 'Let's chat' icon on the bottom right of the page, it means that a representative is online and ready to chat and answer your questions!
Click on the icon to chat with them. If you see a 'Send message' button it means nobody is online right now, but you can send an email instead.
Dietary requirements (in-person events only)
Please indicate any special dietary requirements here. We will try to cater to all dietary requirements and we will write to you if there is any problem.
Sharing your details with others
Please click below if you agree we can share your name, email and postal address with participants and exhibitors, who may use them to contact you.
Please note: you have selected NOT to share your details with participants and exhibitors.
You can click above to change this.
We will use the email address in your EACR account to communicate with you. However, during the checkout process you will need to enter the name and contact details of the person paying for your registration, if this is different to your own details. Please make sure you have this information to hand.
Terms and Conditions
Please read our Membership and Events Terms and Conditions before completing your registration.
Photography and video
Please note that we will be taking photographs and video at the conference for publicity and marketing purposes. If you do not wish to take part please inform the photographer.
The EACR is grateful for the continued support of its Industry Partners: